STENT THROMBOSIS, BLEEDING, AND ANTIPLATELET THERAPY IN THE E-SELECT REGISTRY: ONEYEAR FOLLOW-UP OF 15000 PATIENTS TREATED WITH THE SIROLIMUS-ELUTING CYPHER-SELECT STENT PLUS
نویسندگان
چکیده
منابع مشابه
The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry.
OBJECTIVES This study sought to compare the 1-year safety and efficacy of Cypher Select or Cypher Select Plus (Cordis Corporation, Bridgewater, New Jersey) sirolimus-eluting stents (SES) with the treatment of bare-metal stents (BMS) and drug-eluting stent (DES) in-stent restenosis (ISR) in nonselected, real-world patients. BACKGROUND There is paucity of consistent data on DES for the treatmen...
متن کاملAntiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation.
BACKGROUND The influences of antiplatelet therapy discontinuation on the risk of stent thrombosis and long-term clinical outcomes after drug-eluting stent implantation have not yet been addressed adequately. METHODS AND RESULTS In an observational study in Japan, 2-year outcomes were assessed in 10 778 patients undergoing sirolimus-eluting stent implantation. Data on status of antiplatelet th...
متن کاملSirolimus-eluting stent versus balloon angioplasty for sirolimus-eluting stent restenosis: Insights from the j-Cypher Registry.
BACKGROUND Optimal treatment strategies for restenosis of sirolimus-eluting stents (SES) have not been adequately addressed yet. METHODS AND RESULTS During the 3-year follow-up of 12 824 patients enrolled in the j-Cypher registry, 1456 lesions in 1298 patients underwent target-lesion revascularization (TLR). Excluding 362 lesions undergoing TLR for stent thrombosis or TLR using treatment moda...
متن کاملInterventional Cardiology Sirolimus-Eluting Stent Versus Balloon Angioplasty for Sirolimus-Eluting Stent Restenosis: Insights From the j-Cypher Registry
Mitsuru Abe, MD; Takeshi Kimura, MD; Takeshi Morimoto, MD, MPH; Takuya Taniguchi, MD; Futoshi Yamanaka, MD; Kazuhiro Nakao, MD; Nobuhito Yagi, MD; Nobuaki Kokubu, MD; Yoichiro Kasahara, MD; Yu Kataoka, MD; Yoritaka Otsuka, MD; Atsushi Kawamura, MD; Shunichi Miyazaki, MD; Koichi Nakao, MD; Kenji Horiuchi, MD; Akira Ito, MD; Hiroshi Hoshizaki, MD; Ren Kawaguchi, MD; Manabu Setoguchi, MD; Tsukasa ...
متن کاملOne-year clinical outcomes after sirolimus-eluting coronary stent implantation in diabetics enrolled in the worldwide e-SELECT registry.
BACKGROUND Diabetes mellitus has worse outcome after percutaneous coronary intervention. AIM We assessed stent thrombosis (ST), major adverse cardiac events (MACE), and major bleeding rates at 1 year after implantation of sirolimus-eluting stents (SES) in patients with diabetes mellitus in a large multicenter registry. METHODS From May 2006 to April 2008, 15,147 unselected consecutive patie...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 2010
ISSN: 0735-1097
DOI: 10.1016/s0735-1097(10)61167-9